This Is the Best Argument for Christian Nationalism
Here's Why the U.S. Will Soon Start Revoking Some Passports
NY Times Struggles With Court Rulings, Discrimination, and a Complaint by an Anonymous...
Gavin Newsom Is So Serious About Cracking Down on Crime, He's Doing This...
Bernie Sanders Attacks Google Founder and It's Pathetic
New York Turns Blind Eye to Crazy Man Terrorizing Bronx Apartment Building
Victor Davis Hanson Reveals How Democrats Plan to Hold On to Power
The Future of LA: Watch This Mayoral Candidate Blame a Company For Making...
Judge Allows Cameras in Charlie Kirk Murder Trial
Mexican National Faces Up to 15 Years for Running Alien Smuggling Operation Across...
Treasury Sanctions 10 Entities Across Middle East, Asia, and Europe Over Iran Arms...
New USDA Rule Will Demand SNAP Stores Stock More 'Real Food'
Could Courts Overturn California's Congressional Map Next? This Senator Thinks So.
DOJ Moves to Strip Citizenship From Convicted Cuban Spy
Rhode Island Man Charged With Using Identities of 18 People — Some Deceased...
Tipsheet

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness
AP Photo/Jose Luis Magana

President Donald Trump has signed an executive order to speed the use of psychedelic drugs as a potential treatment for serious mental illness. 

The order directs the Food and Drug Administration to the Commissioner’s National Priority Vouchers to appropriate psychedelic drugs that have received breakthrough therapy designations for treating serious mental illnesses. 

Advertisement

That designation aims to ensure that people with serious mental illnesses, including veterans, can receive help. America’s veterans have a suicide rate of twice that of non-veterans. For over 20 years, there have been more than 6,000 veteran suicides per year.

The Order further directs the FDA and the Drug Enforcement Agency to establish a pathway for eligible patients to access investigational psychedelic drugs, including ibogaine compounds, that are under FDA review and that have met basic safety requirements under President Trump’s landmark Right to Try Act.

The Order requires the Secretary of Health and Human Services to allocate $50 million through the Advanced Research Projects for Health program to match investments made by state governments to advance research into psychedelic programs for populations with serious mental illness.

The HHS and FDA will collaborate with the Department of Veterans Affairs and the private sector to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies. 

The order tells the Attorney General to review these drugs upon successful completion of Phase 3 clinical trials so they can be rescheduled, if appropriate. 

Advertisement

Today, over 14 million American adults have a serious mental illness— a diagnosable mental, behavioral, or emotional disorder that substantially interferes with a person’s life and ability to function.


Advertisement



Editor’s Note: Do you enjoy Townhall’s conservative reporting that takes on the radical Left and woke media? Support our work so that we can continue to bring you the truth.

Join Townhall VIP and use promo code FIGHT to receive 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement